The Leapfrog Group Responds to CMS CY 2027 OPPS Final Rule

November 17, 2026

On November 4, 2026, the Centers for Medicare & Medicaid Services (CMS) issued its Calendar Year (CY) 2027 Hospital Outpatient Prospective Payment System (OPPS) final rule. The Leapfrog Group reviewed the final rule to assess how CMS addressed recommendations submitted during the public comment period.

While Leapfrog supports several finalized changes, we remain deeply concerned by the lack of progress in expanding quality and safety measures for ambulatory surgery centers (ASCs). As more procedures move from hospitals to outpatient settings, patients and purchasers need meaningful, publicly reported information to evaluate the safety and quality of care.

Key Outcomes of the Final Rule

  • Ambulatory Surgery Center Quality Reporting: CMS did not expand quality reporting requirements for ASCs, despite Leapfrog's recommendations to strengthen measurement and public reporting, including anesthesia outcomes and surgical site infections. This remains a significant gap in transparency and accountability for outpatient surgical care.
  • Inpatient Only List: CMS finalized the removal of 637 additional services from the Inpatient Only List for CY 2027. Leapfrog opposed eliminating services from the list without first establishing more comprehensive quality and safety reporting for outpatient procedures and ASCs.
  • Hospital Outpatient Quality Reporting: CMS finalized changes to data validation and appeals procedures supported by Leapfrog, including targeted validation and the inclusion of electronic clinical quality measures (eCQMs) in the existing validation process.
  • Hospital Price Transparency: CMS acknowledged feedback submitted in response to its request for information and indicated that it would consider comments in future rulemaking. Leapfrog continues to emphasize that meaningful price transparency must be paired with quality and safety information so patients and purchasers can make informed health care decisions.

Leapfrog also supported the removal of a colonoscopy follow-up documentation measure, which CMS finalized.

We will continue to advocate for stronger quality measurement, public reporting and transparency to ensure patients and purchasers have the information they need to make informed decisions about their health care.

Visit Newsletter